It is a entertainment private limited company based in Pune, Maharashtra, India, established in 2009.
2009 | Pune, Maharashtra, India | Converted to LLPAryaman Pharmaceuticals Private Limited, a converted to llp private limited company, was established on 10 July 2009 in Pune, Maharashtra, India. Engaging in motion picture within the entertainment sector, it holds CIN: U46497PN2009PTC134298. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Suman Prabhakar Palwe (Additional Director), Charudatta Prabhakar Palwe (Additional Director). Past directors included Pankaja Charudatta Palwe, Prabhakar Supada Palve, Charudatta Prabhakar Palwe. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Off No 302 A City Bay Sr No. A/3C/1 A/1 348 A/1/1 F.P., Pune, Maharashtra, 411001.
U46497PN2009PTC134298
134298
10 July 2009
₹0.10 M
₹0.10 M
Roc Pune
Unlisted
Converted to LLP
Explore comprehensive insights into Aryaman Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suman Prabhakar Palwe | Additional Director | 05 Dec 2024 | Current |
| Charudatta Prabhakar Palwe | Additional Director | 05 Dec 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Mar 2016 | Past |
| Pramod Abcsdd | Additional Director | 05 Dec 2024 | Past |
| Pramod Abcsdd | Director | 21 Feb 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aryaman Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Aryaman Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Aryaman Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Aryaman Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aryaman Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Suman Prabhakar Palwe was appointed as a Additional Director was appointed as a Additional Director on 05 Dec 2024 & has been associated with this company since 11 months 20 days . was documented.
Charudatta Prabhakar Palwe was appointed as a Additional Director was appointed as a Additional Director on 05 Dec 2024 & has been associated with this company since 11 months 20 days . was recorded as a recent event.
The activity Aryaman Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Aryaman Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was completed.
Aryaman Pharmaceuticals Private Limited was registered on 10 Jul 2009 with Roc Pune & aged 16 years 4 months as per MCA records. was recorded as a recent event.
The CIN of Aryaman Pharmaceuticals Private Limited is U46497PN2009PTC134298.
Aryaman Pharmaceuticals Private Limited is headquartered at Off No 302 A City Bay Sr No. A/3C/1 A/1 348 A/1/1 F.P., Pune, Maharashtra, 411001.
Aryaman Pharmaceuticals Private Limited was incorporated on 10 July 2009.
The current directors of Aryaman Pharmaceuticals Private Limited are
The primary industry of Aryaman Pharmaceuticals Private Limited is Entertainment.
Aryaman Pharmaceuticals Private Limited is unlisted.
The authorized capital of Aryaman Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Aryaman Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX